The global disposable syringes market size was estimated at USD 14.18 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030. The market is primarily driven by factors, such as an increase in technological advancements and a rise in the incidence of chronic diseases. Moreover, the increasing adoption of safety syringes and the rising prevalence of diabetes drive market growth. Leading manufacturers focus on technological innovations, an increase in technological advancements, and the development of advanced products to gain substantial market shares, propelling its growth. The increasing prevalence of chronic disorders, such as diabetes, can be managed by self-injecting medication.
The rising cases of chronic diseases and an increasing number of vaccinations that make extensive use of syringes, such as single-use and disposable syringes, are enhancing global market growth. According to the International Diabetes Federation (IDF) Diabetics Atlas, the diabetic population is anticipated to grow by 46.0% reaching 643 million (1 in 9 adults) by 2030, and likely to majorly rise in middle-income countries, as compared to the developed countries. The adoption and development of disposable medical supplies for the prevention of infections during hospital operations is another key factor driving the market growth.
Growing self-injecting medication brings the need for safety while using syringes, whereas nowadays, with the advent of disposable syringes, it is much easier to eliminate the risk to a certain extent, by throwing away the needle immediately after the use of injection so that no cross contamination occurs. Mölnlycke Health Care AB reports that every year, 70 million surgeries are carried out in Europe. This has resulted in a projected increase in product sales over subsequent years, driving the market growth.
The hospital end-use segment accounted for the largest revenue share of around 52% in 2022. Hospitals are often the preferred choice for patients seeking treatment due to their convenient accessibility and established trust. Patients can also visit the hospital to seek fluid therapy, which administers fluids to patients’ body intravenously or subcutaneously. Consequently, the demand for dispersing syringes in hospitals continues to rise.
The hospital segment also is estimated to register the fastest CAGR of 6.4% from 2023 to 2030. Many industry players and government bodies have been prioritizing health by spreading awareness about the use of syringes and improving patient accessibility. To achieve these goals, organizations collaborate with hospitals for training, product distribution, and adoption of smart syringes that drive the demand for disposable syringes within healthcare facilities.
North America dominated the global market in 2022 and accounted for the largest share of 42% of the overall revenue. It is expected to maintain its dominance throughout the forecast period. Major factors contributing to its growth include the increasing geriatric population, the growing burden of diabetes due to lifestyle changes, and the high adoption of safety syringes. Some market leaders, such as Medtronic and BD, Nipro Corporation, and Terumo Corp., have their operational headquarters in North America, which is also contributing to regional market growth.
MEA is expected to grow at the fastest CAGR of 6.9% from 2023 to 2030. Diabetes is becoming more common because of unhealthy lifestyles and other risk factors, such as obesity, genetics, low awareness levels, and high cost of health care. It is interesting to note an upsurge of diabetic subjects in Middle East. The highest prevalence of diabetes across the globe is in Kuwait, Saudi Arabia, and Bahrain. Therefore, the product has a high demand, which is fulfilled by the development of extensive government policies and diabetic care plans to reduce these figures in this region.
The conventional syringes segment accounted for the largest share of around 53% in 2022. The use of injection and auto-injectors comprises the use of needles. Conventional syringes are the most practiced and used syringes in homecare settings. For instance, conventional disposable syringes guarantee protection for the patient receiving the injection. Related to this, many key players have introduced conventional syringes in the market. The safety syringes segment is estimated to register the fastest CAGR of 6.4% from 2023 to 2030.
Safety syringes are required for most diagnostic and therapeutic approaches for chronic diseases since they are essential during medication administration and tests, resulting in a rising product demand. In June 2021, Hindustan Syringes and Medical Devices Ltd. entered a technical collaboration with Star Syringes of the UK to launch disposable safety needles with sharps injury prevention features under the Disposjekt Needle brand. They are convertible to regular dispo valve disposable syringes or can be attached to K.O.J.A.K. auto-disable safety needles.
The market is highly competitive, with a large number of manufacturers accounting for most of the market share. Syringe launches, approvals, strategic acquisitions, and innovations are just a few of the important business strategies used by market participants to maintain and grow their global reach. For instance, F. Hoffmann-La Roche Ltd., in November 2022, partnered with the Mark Cuban Cost Plus Drug Company to offer affordable access to blood glucose testing supplies in the U.S. The American Heart Association projects that 45.1% of the U.S. population, i.e. over 130 million adults, is expected to be affected by any cardiovascular disease (CVD) by 2035. Furthermore, about 655,000 Americans die from heart disease each year; it accounts for 1 out of 4 deaths.
Report Attribute |
Details |
Market size value in 2023 |
USD 14.96 billion |
Revenue forecast in 2030 |
USD 22.81 billion |
Growth rate |
CAGR of 6.2% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Syringe type, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Medtronic; Nipro Corp.; Fresenius Kabi AG; Baxter; Braun Medical, Inc.; Becton, Dickinson and Company (BD); Flextronics International Vita Needle Company; Terumo Corp.; Novo Nordisk; Ultimed, Inc.; Henke-Sass; Wolf; Retractable Technologies, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the disposable syringes market report based on syringe type, end-use, and region:
Syringe Type Outlook (Revenue, USD Million, 2018 - 2030)
Conventional Syringes
Safety Syringes
Retractable Safety Syringes
Non-retractable Safety Syringes
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital
Outpatient Facilities
Research & Manufacturing
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global disposable syringes market size was estimated at USD 14.18 billion in 2022 and is expected to reach USD 14.96 billion in 2023.
b. The global disposable syringes market is expected to grow at a compound annual growth rate of 6.21% from 2023 to 2030 to reach USD 22.81 billion by 2030.
b. Asia pacific dominated the disposable syringes market with a share of 31.14% in 2022. This is attributable to the high prevalence of diseases and increasing preference for injectable drugs.
b. Some key players operating in the disposable syringes market include B. Braun Melsungen AG, Fresenius Kabi AG, Baxter International, Inc., Flextronics International Vita Needle Company, Terumo Corporation, Novo Nordisk, UltiMed, Inc., Henke-Sass, Wolf;Covidien; and BD.
b. Key factors that are driving the disposable syringes market growth include growing demand for injectable drugs, safe and patient-friendly drug delivery, and increasing government and organizations initiatives.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."